CD34 and neoplasm: The use of purified CD34+ stem cells may offer an opportunity to reshape the repertoire of the reconstituting ‘naïve’ T lymphocytes to include tumour-associated self-antigens, thus overcoming any tumour-induced suppression of antitumour immunity (Sondak et al, 1991).